vs
Side-by-side financial comparison of IT TECH PACKAGING, INC. (ITP) and Xilio Therapeutics, Inc. (XLO). Click either name above to swap in a different company.
IT TECH PACKAGING, INC. is the larger business by last-quarter revenue ($25.6M vs $13.7M, roughly 1.9× Xilio Therapeutics, Inc.). Xilio Therapeutics, Inc. runs the higher net margin — 75.7% vs -5.7%, a 81.4% gap on every dollar of revenue. IT TECH PACKAGING, INC. produced more free cash flow last quarter ($1.5M vs $-2.1M).
IT TECH PACKAGING, INC. is a paper manufacturing enterprise primarily operating in China. It produces and distributes a diverse portfolio of paper products including corrugated packaging paper, boxboard, and printing-use cultural paper, serving sectors such as consumer goods packaging, logistics, and commercial printing across its core market.
Xilio Therapeutics is a clinical-stage biotechnology company dedicated to developing novel tumor-selective immunotherapies for cancer treatment. Its product pipeline features candidates engineered to trigger anti-tumor immune responses specifically inside tumor microenvironments, reducing systemic toxicities, and it primarily targets oncology patient populations in North America and other global markets.
ITP vs XLO — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.6M | $13.7M |
| Net Profit | $-1.4M | $10.4M |
| Gross Margin | 7.9% | — |
| Operating Margin | -3.9% | -86.5% |
| Net Margin | -5.7% | 75.7% |
| Revenue YoY | 2.1% | — |
| Net Profit YoY | 26.6% | 179.1% |
| EPS (diluted) | $-0.11 | $-3.74 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $13.7M | ||
| Q3 25 | $25.6M | $19.1M | ||
| Q2 25 | $24.8M | $8.1M | ||
| Q1 25 | $10.9M | $2.9M | ||
| Q4 24 | $17.6M | — | ||
| Q3 24 | $25.1M | — | ||
| Q2 24 | $26.2M | — | ||
| Q1 24 | $6.9M | — |
| Q4 25 | — | $10.4M | ||
| Q3 25 | $-1.4M | $-16.3M | ||
| Q2 25 | $-2.0M | $-15.8M | ||
| Q1 25 | $-3.5M | $-13.3M | ||
| Q4 24 | $-4.0M | — | ||
| Q3 24 | $-2.0M | — | ||
| Q2 24 | $-77.7K | — | ||
| Q1 24 | $-3.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | 7.9% | — | ||
| Q2 25 | 5.1% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 6.3% | — | ||
| Q3 24 | 7.6% | — | ||
| Q2 24 | 12.4% | — | ||
| Q1 24 | 5.8% | — |
| Q4 25 | — | -86.5% | ||
| Q3 25 | -3.9% | -10.1% | ||
| Q2 25 | -7.1% | -177.7% | ||
| Q1 25 | -31.0% | -472.7% | ||
| Q4 24 | -21.5% | — | ||
| Q3 24 | -5.8% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | -51.0% | — |
| Q4 25 | — | 75.7% | ||
| Q3 25 | -5.7% | -85.4% | ||
| Q2 25 | -7.9% | -196.0% | ||
| Q1 25 | -32.2% | -452.7% | ||
| Q4 24 | -22.9% | — | ||
| Q3 24 | -7.9% | — | ||
| Q2 24 | -0.3% | — | ||
| Q1 24 | -54.6% | — |
| Q4 25 | — | $-3.74 | ||
| Q3 25 | $-0.11 | $-0.11 | ||
| Q2 25 | $-0.16 | $-0.16 | ||
| Q1 25 | $-0.35 | $-0.18 | ||
| Q4 24 | $-0.40 | — | ||
| Q3 24 | $-0.20 | — | ||
| Q2 24 | $-0.01 | — | ||
| Q1 24 | $-0.37 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $137.5M |
| Total DebtLower is stronger | $4.7M | — |
| Stockholders' EquityBook value | $152.0M | $35.3M |
| Total Assets | $175.7M | $154.7M |
| Debt / EquityLower = less leverage | 0.03× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $137.5M | ||
| Q3 25 | — | $103.8M | ||
| Q2 25 | — | $121.6M | ||
| Q1 25 | — | $89.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $4.7M | — | ||
| Q2 25 | $4.7M | — | ||
| Q1 25 | $4.7M | — | ||
| Q4 24 | $4.7M | — | ||
| Q3 24 | $8.9M | — | ||
| Q2 24 | $11.3M | — | ||
| Q1 24 | $11.4M | — |
| Q4 25 | — | $35.3M | ||
| Q3 25 | $152.0M | $-8.1M | ||
| Q2 25 | $152.3M | $7.1M | ||
| Q1 25 | $152.8M | $10.7M | ||
| Q4 24 | $156.1M | — | ||
| Q3 24 | $164.3M | — | ||
| Q2 24 | $163.5M | — | ||
| Q1 24 | $164.3M | — |
| Q4 25 | — | $154.7M | ||
| Q3 25 | $175.7M | $133.7M | ||
| Q2 25 | $175.2M | $133.8M | ||
| Q1 25 | $175.2M | $103.7M | ||
| Q4 24 | $177.5M | — | ||
| Q3 24 | $190.0M | — | ||
| Q2 24 | $191.4M | — | ||
| Q1 24 | $177.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.03× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 0.03× | — | ||
| Q3 24 | 0.05× | — | ||
| Q2 24 | 0.07× | — | ||
| Q1 24 | 0.07× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.5M | $-2.0M |
| Free Cash FlowOCF − Capex | $1.5M | $-2.1M |
| FCF MarginFCF / Revenue | 5.9% | -15.3% |
| Capex IntensityCapex / Revenue | 0.0% | 0.7% |
| Cash ConversionOCF / Net Profit | — | -0.19× |
| TTM Free Cash FlowTrailing 4 quarters | $3.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-2.0M | ||
| Q3 25 | $1.5M | $-17.5M | ||
| Q2 25 | $1.4M | $-14.5M | ||
| Q1 25 | $-2.5M | $29.0M | ||
| Q4 24 | $3.5M | — | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | $721.9K | — | ||
| Q1 24 | $624.4K | — |
| Q4 25 | — | $-2.1M | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $1.3M | $-14.9M | ||
| Q1 25 | $-2.5M | $29.0M | ||
| Q4 24 | $3.5M | — | ||
| Q3 24 | $1.2M | — | ||
| Q2 24 | $668.3K | — | ||
| Q1 24 | $615.4K | — |
| Q4 25 | — | -15.3% | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 5.4% | -184.0% | ||
| Q1 25 | -22.8% | 988.3% | ||
| Q4 24 | 19.6% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 2.5% | — | ||
| Q1 24 | 9.0% | — |
| Q4 25 | — | 0.7% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.1% | 5.0% | ||
| Q1 25 | 0.1% | 0.8% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | -0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
